Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy

OBJECTIVE: To report side effect frequency and severity in patients with major depressive disorder (MDD) receiving escitalopram and aripiprazole adjunctive therapy and to examine whether pretreatment anxious depression is associated with the number and presence of specific side effects. METHODS: 188...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinola, Caroline W., Khoo, Yuelee, Parmar, Roohie, Demchenko, Ilya, Frey, Benicio N., Milev, Roumen V., Ravindran, Arun V., Parikh, Sagar V., Ho, Keith, Rotzinger, Susan, Lou, Wendy, Lam, Raymond W., Kennedy, Sidney H., Bhat, Venkat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120722/
https://www.ncbi.nlm.nih.gov/pubmed/35333448
http://dx.doi.org/10.1002/brb3.2555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120722/
https://www.ncbi.nlm.nih.gov/pubmed/35333448
http://dx.doi.org/10.1002/brb3.2555

Ejemplares similares